Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Paracentesis × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Cyclophosphamide 1236 Cisplatin 1164 Paclitaxel 1084 Radiotherapy 1069 Carboplatin 1032 Gemcitabine 1014 Docetaxel 938 Bevacizumab 855 Fluorouracil 738 Doxorubicin 665 Dexamethasone 622 Capecitabine 615 Rituximab 597 Oxaliplatin 576 Etoposide 564 pembrolizumab 540 Filgrastim 528 Irinotecan 527 Cytarabine 488 Leucovorin 478 Nivolumab 437 Vincristine 427 Prednisone 394 Bortezomib 392 Cetuximab 385 Erlotinib Hydrochloride 383 Trastuzumab 373 Methotrexate 354 Pemetrexed 350 Lenalidomide 350

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04032600 2020-12-08

ATLANTIS

Charite University, Berlin, Germany

Phase NA Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡